P reterm labor and birth has a genetic predisposition. [1] [2] [3] [4] [5] Such a concept is supported by the following evidence: (1) demonstration of familial aggregation, [6] [7] [8] [9] [10] [11] [12] which is defined as the cooccurrence of a trait in members of a family that cannot readily be accounted for by chance, (2) measures of heritability, [13] [14] [15] [16] [17] [18] [19] (3) detection of disease-susceptibility genes, 20 and (4) racial disparity in preterm birth rates [21] [22] [23] [24] [25] [26] [27] [28] that could be associated with differences in frequency of risk-predisposing alleles. [29] [30] [31] [32] [33] Studies in twins have demonstrated a heritability range from 17e40%. 8, 9, 14, 34 Moreover, polymorphisms in several genes have been associated with spontaneous preterm labor with and without intact membranes. 5, 12, 24, 30, 33, Studies that combine twin-and family-based approaches have shown that both the maternal and fetal genomes contribute to the timing of delivery and that environmental factors, depending on the population, also play a key role. 180 Maternal and fetal genetic factors, combined, are estimated to contribute 30% of the risk for early delivery. 180 There has been considerable interest in the identification of genetic variants that influence the inflammatory response in reproductive tissues that could lead to preterm birth, particularly those variants and their interacting environmental factors that could account for differences in the incidence of preterm birth among populations. 165, 170 Candidate gene approach One frequently used technique to identify genetic risk factors for complex disorders is the candidate gene approach that directly tests the effects of specific genetic variants of a selected gene in an association study. 181 Candidate gene studies may include the detection of genetic variants, which include single nucleotide polymorphisms (SNPs), usually variants that have functional significance (eg, alter protein function or expression), and relatively high minor allele frequencies in a single gene (Figure 1 ) or multiple genes ( Figure 2 ). Such studies can be performed relatively quickly and in an inexpensive manner. 181 The major problem with candidate gene studies is that investigators must have a deep understanding of the pathophysiologic condition of the disease to select a candidate gene. 181 Therefore, a central limitation of this type of study is that it does not identify genetic locations other than those suspected to influence disease. 182 Yet, candidate gene studies do not require large families with both affected and unaffected members and can be performed with unrelated cases and control subjects or with small families. 181 In addition, these types of studies are suitable for the identification of genes implicated in common and complex diseases, for which the risk associated with any given candidate gene is minimal. 183, 184 However, the case and control cohorts must be adequate, based on a sample size calculation.
Candidate gene studies have shown that some polymorphisms in genes coding for matrix metalloproteinases, 20, 164 cytokines/cytokine receptors, 41, 48, 49, 51, 53, 59, 61, 63, 80, 82, 124, 125, 153, 185 and other components of the innate immune system 60, 118 are significantly associated with preterm birth. Yet, replication of the majority of the positive results has not been achieved. 165, 170, 186, 187 The disparate results could be related to the polymorphism(s) investigated, inconsistent phenotype definitions, failure to account for multiple testing, the sample size (which has usually been quite small), and population differences, which include different proportions of individuals of different race/ethnicity in cases and control subjects (population stratification).
Genome-wide association studies
Genome-wide association studies (GWAS) emerged as the preeminent instrument for discovering genetic loci that contribute to disease risk and quantitative traits. GWAS include the analysis of hundreds of thousands of SNPs across the entire genome ( Figure 3 ) without bias imposed by preexisting models and provide the opportunity of identifying the location of novel genes, regulatory loci, and pathways not previously considered. 188, 189 These studies have been crucial to the development of our current understanding of the architecture of complex traits. When GWAS became popular, the dominant paradigm in the field was "the common disease-common variant hypothesis." [190] [191] [192] [193] This paradigm posits that common diseases are attributable to DNA variants that are present in >1e5% of the population, that there are many of these DNA variants, and that each contributes a small amount to the total risk of a particular disease. 183, 191, 194 Moreover, DNA variants may have an additive or a multiplicative effect in the determination of susceptibility to a particular trait or disease. 195 GWAS scored important successes in the identification of DNA variants that predispose to some diseases such as age-related macular degeneration (related to a gene encoding for complement factor H 196 ) and Crohn's disease (DNA variants in the IL23R gene 197 ). These successes have occurred because these specific DNA variants contribute largely to explain the heritability of these conditions. However, after many GWAS, it has become clear that most common variants that have been identified so far confer only small increments in risk and therefore would explain a small proportion of the familial clustering by genetic factors. This finding has raised the question of how to explain "the missing heritability" 198 of many complex traits.
The missing heritability problem has given rise to alternative paradigms that attribute genetic predisposition to (1) a large number of small-effect common variants across the entire allele frequency spectrum, 199 (2) a large number of largeeffect rare variants, 200 or (3) a combination of genotypic, environmental, and epigenetic interactions. 201, 202 A full discussion of this subject is beyond the scope of this article, and the interested reader is referred to publications that specifically address these issues. 199, [203] [204] [205] [206] The practical issue is that, with the advancements in sequencing techniques, it is now possible to perform whole exome sequencing or whole genome sequencing, which allows the examination of the role of rare variants to the heritability of complex traits.
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GWAS have been performed using panels of SNPs that cover the entire genome ( Figure 3) . 203 Most of these SNPs have not been within the coding sequences and serve only to mark a chromosomal location (genetic locus) where a disease-related gene may reside. 195 Further refined mapping and DNA sequence analysis are needed to follow up any GWAS finding to establish which DNA variants are responsible for the trait/phenotype. 195 Moreover, a large number of cases and control subjects are necessary to identify the locus (or loci) for the discovery of its statistically significant contribution to a trait. 206 The GWAS of preterm birth reported to date have not been informative nor have they confirmed the importance of the innate immune candidate genes. They also have not yielded replicable loci. The largely negative results could reflect the complexity of the premature labor phenotype (a syndrome in which genetic predisposition could contribute to each mechanism of disease), the limitations in the characterization of the phenotype, the limitations in sample size, or a fundamental problem with the "common variant/common disease" paradigm. A very recent publication that examined a large population of >40,000 women and replication cohorts of >8000 women identified several maternal loci (EBF1, EEFSEC, and AGTR2) that may contribute to preterm birth in White women. 207 EBF1 encodes a protein implicated in B-cell development; EEF-SEC encodes a protein involved in the production of selenoproteins; and AGTR2 encodes the type 2 angiotensin II receptor. Although none of these loci has a direct role in innate immunity or the inflammatory mechanisms implicated to be important in spontaneous preterm birth, they may have a role in other mechanisms of disease for preterm labor and provide new lines of investigation. The relevance of the DNAvariants to spontaneous preterm birth in populations other than those of European ancestry will undoubtedly be a subject of future research to determine how they predispose to spontaneous preterm birth and whether they confer risk in other ethnic groups, such as African American or Hispanic women.
Whole exome sequencing
Whole exome sequencing (WES) entails the full characterization (nucleotide composition) of the protein-coding genes in a genome, known as the exome (Figure 4 ), which represents <2% of the genome but contains 85% of known disease-related variants. 208 The value of WES is based on the concept that rare, as well as more common, mutations in coding sequences of multiple genes make an important contribution to complex traits and common diseases. Based on their effect on the DNA sequence, mutations are clarified into (1) point mutations, those characterized by a change (insertion/deletion or substitution) of only 1 nucleotide base in a DNA sequence ( Figure 5 , A), and (2) frame-shift mutations, those caused by the insertion/deletion of a number of nucleotides in a DNA sequence that is not divisible by 3, which results in the change of the reading frame (the grouping of the codons) and, therefore, in a different translation from the original (different amino acid sequence; Figure 5 , B). Based on their effect on the protein, mutations are also clarified into (1) nonsense mutations in which a sense codon that 
Candidate gene approach
This technique includes the detection of genetic variants (including single nucleotide polymorphisms) in a single gene within the genome. Single nucleotide polymorphisms may fall within coding sequences of genes (exons; blue), noncoding regions of genes, or in the intergenic regions (introns; red).
SNPs, single nucleotide polymorphisms.
Strauss. Spontaneous preterm birth, inflammation, and genetics. Am J Obstet Gynecol 2018.
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corresponds to 1 of the 20 amino acids is changed to a chain-terminating (Stop) codon ( Figure 6 , A) and (2) missense mutations, which include a single nucleotide change that results in a codon that codes for a different amino acid (Figure 6 , B). Missense mutations can be further clarified into (a) silent mutations, which do not have an effect on the protein because the change in the codon does not result in a change in the amino acid (eg, CCA, CCG, CCC, and CCT encode for the same amino acid, glycine), (b) conservative mutations, in which the new amino acid is the same type as the original (eg, glutamic acid is replaced with aspartic acid; both are acidic amino acids), and (c) nonconservative mutations, in which an amino acid is not the same type as the original (eg, serine, a small polar amino acid is replaced with L-phenylalanine, a large nonpolar aromatic amino acid). Therefore, WES can identify damaging mutations that can disrupt a protein amino acid sequence and truncate, inactivate, or diminish protein function that contributes to complex traits, such as preterm birth. 209, 210 There are limitations to WES; it can miss structural variation 211 and cannot detect important intragenic variation, which includes regulatory elements that control gene expression. In addition, WES, despite its name, can also miss some exons; if the causal variants lie within the missing exons, they will not be identified. 211 The currently used WES capture methods require sequencing of a large number of bases, which can make this technique expensive and comparable to low-coverage whole genome sequencing. 211 Whole genome sequencing not only determines the exome but also provides information on variants in highly evolutionary conserved noncoding regions and on other variants throughout the genome 211 ( Figure 7 ). However, lowcoverage whole genome sequencing may miss many of the variants; therefore, high-coverage WES is the method of choice for complex traits because it is affordable and can now be performed in newly developed platforms. 211 The first study to use WES in idiopathic preterm birth was conducted with 10 mothers from densely affected families that included 2 mother-daughter pairs. 12 It was reported that maternal coding variants in complement receptor 1 (CR1) were implicated in the pathophysiologic condition of preterm birth. 12 Using WES, we discovered that genes that negatively regulate the innate immune response (eg, toll-like receptors [TLRs] and inflammasome components) or that encode proteins that defend the host against microbes (eg, defensins) harbor mutations or damaging variants that enhance inflammation in the fetal membranes, resulting in preterm premature rupture of the membranes (PPROM) in neonatal DNA collected from pregnancies hosted by 
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African American mothers. 210 The PPROM case and term control neonates had similar proportions of West African ancestry, which reduced the risk of spurious associations due to population stratification. 210 Relevant to these findings, polymorphisms in the gene encoding TLR-10, a TLR that negatively regulates the inflammatory pathway, 212 have been associated with preterm birth. 213 Importantly, the DEFB1 and MBL2 nonsense mutations have allele frequencies >10-fold greater in African populations compared to European populations (DEFB1 African, 0.00615; European, 0.00018; MBL2: African, 0.006537; European, 0.00004). These population differences observed in mutant alleles may help explain racial/ ethnic differences in PPROM and preterm birth.
In addition, we showed that a number of these mutations/damaging missense variants would be associated with inflammatory conditions that occur in women who deliver preterm, 210 210 We identified 14 nonsense and damaging frameshift mutations and a number of predicted damaging missense variants in genes that negatively regulate the innate immune system or that encode antimicrobial proteins 
Genome-wide association approach
This technique includes the analysis of hundreds of thousands of single nucleotide polymorphisms across the entire genome without bias imposed by preexisting models and provides the opportunity to identify novel genes, regulatory loci, and pathways not previously considered. Single nucleotide polymorphisms may fall within coding sequences of genes (exons; blue), non-coding regions of genes, or in the intergenic regions (introns; red). Data analysis results in candidate single nucleotide polymorphisms that require further validation.
SNP, single nucleotide polymorphisms
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(examples of which are presented in Supplementary Table  210 ) . Noteworthy among the genes are those that protect the host against microbes (eg, defensin
, the negative TLR regulator, TLR10, and multiple inflammasome genes, eg, caspase recruitment domain family member 8 (CARD8), NLR family pyrin domain containing 10 (NLRP10), NLRP12, and nucleotide oligomerization domain (NOD2). 210 A brief review on the role of inflammation, ie, the inflammasome and NOD proteins, in spontaneous preterm labor is given later in the article.
Of the 14 mutations identified, 10 had higher nominal allele frequencies in PPROM cases compared to the control subjects in an expanded cohort of 188 PPROM cases and 175 term control subjects. 210 A test of genetic burden (which assesses the potential impact of the aggregate mutational load) for the 14 mutations revealed a statistically significant association with PPROM risk (P < .05). 210 The mutations and predicted damaging missense variants identified in cases of PPROM, for the most part, were very rare alleles, and the majority were heterozygous mutations. 210 However, cumulatively, they may have a population impact. This is exemplified by mutations and predicted damaging missense variants in the genes involved in the NOD2 pathway, which were found in 10 of 76 PPROM neonates and none in the 43 term control subjects. 210 With 76 PPROM cases (152 chromosomes), there was a >75% chance to detect minor alleles with a frequency of 0.005. Thus, very rare mutations could have gone undetected. 210 The mutations reported by Modi et al 210 were found in genes encoding for innate immune mediators, which supports the concept that inflammation plays a central role in the mechanisms of disease for spontaneous preterm labor and birth.
Spontaneous preterm labor/birth: the role of inflammation Preterm labor is a syndrome caused by multiple pathologic processes. 214 
FIGURE 4 Whole exome sequencing approach
This technique entails the full characterization (nucleotide composition) of the protein-coding genes in a genome, known as the exome, which represents <2% of the genome but contains 85% of known disease-related variants. Data analysis results in the identification of mutations in the exome.
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Intraamniotic inflammation has been linked causally to spontaneous preterm labor and delivery. This pathologic inflammatory process can be caused by microorganisms invading the amniotic cavity (ie, intraamniotic infection) or danger signals/alarmins released during cellular stress or death (ie, sterile intraamniotic inflammation). 214, 237, [248] [249] [250] [251] [252] [253] [254] [255] In both scenarios, cytokines, such as interleukin (IL)-1, 256-261 IL-6, 250, [262] [263] [264] [265] [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] IL-8, [276] [277] [278] [279] and tumor necrosis factor alpha, [280] [281] [282] [283] [284] [285] among others, 286-301 play a central role in the pathophysiologic condition of preterm labor and birth. [235] [236] [237] Of all these cytokines, IL-1b is a central mediator in the pathologic process of preterm labor because it can stimulate the expression and release of other labor mediators, such as prostaglandins. 229, [302] [303] [304] [305] [306] [307] Indeed, the administration of IL-1b causes preterm birth in mice 257, 260 and nonhuman primates, 227 ,308-314 which can be abrogated by the administration of the IL-1b receptor antagonist, 259 which confirms a key role for this cytokine in the mechanisms responsible for preterm labor in the context of inflammation.
"The inflammasome" in spontaneous preterm labor The inflammasome is not another "ome." It is a multiprotein complex located in the cytoplasm of cells; activation induces the transformation of pro-IL-1b (immature form) into the mature/bioactive form of IL-1b [315] [316] [317] [318] [319] [320] [321] [322] [323] by the actions of active caspase-1 (CASP-1).
324-329 Figure 8 shows the inflammasome complex that contains (1) a pattern recognition receptor or sensor molecule, (2) the adaptor protein ASC (an apoptosis-associated speck-like protein), and (3) proe caspase-1 (pro-CASP-1).
315-323
The apoptosis-associated speck-like protein component of the inflammasome protein is encoded by PYCARD and includes 2 death-fold domains: 1 pyrin domain and 1 caspase activation and recruitment domain (CARD). 330, 331 On activation, the inflammasome induces the release of active forms of CASP-1 that, in turn, participates in the processing of mature IL-1b and IL-18 [324] [325] [326] [327] [328] 332 ( Figure 8 ), inducing a proinflammatory programmed cell death termed pyroptosis. [333] [334] [335] Evidence in support of the participation of the inflammasome in the mechanisms of labor associated with inflammation 336 is that the amniotic fluid concentrations of CASP-1, 337 IL-1b, 256, 258 and IL-18 291 are greater in women who have spontaneous preterm or term labor with intraamniotic infection/inflammation than in those without this clinical condition. In addition, the amounts of NLR family pyrin domain-containing protein 3 (NLRP3, an inflammasome-recruiting pattern recognition receptor), active forms of CASP-1 and mature forms of IL-1b and IL-18 are increased in the chorioamniotic membranes from women who underwent spontaneous preterm 338 or term 339 labor with acute histologic chorioamnionitis, compared to those without this placental lesion. Acute histologic chorioamnionitis is associated with intraamniotic infection and/or inflammation [340] [341] [342] [343] [344] [345] [346] [347] [348] [349] [350] and sterile intraamniotic inflammation. [250] [251] [252] 351 Therefore, the inflammasome is implicated in the physiologic 352, 353 and pathologic 338,339,354 inflammatory processes of labor (Figure 8 ).
NOD proteins in spontaneous preterm labor A second set of pattern recognition receptors implicated in the mechanisms that lead to the inflammatory process associated with labor are the NOD1 and NOD2 proteins. 338, 339, 352, 354 These intracellular molecules recognize bacterial peptidoglycan segments [355] [356] [357] [358] [359] [360] [361] [362] [363] and alarmins 364 without forming inflammasomes. Instead, the NOD proteins directly activate nuclear factor kappa B proinflammatory signaling, which induces the expression of proeIL-1b and proeIL-18.
355,365 NOD Classification of mutations based on their effect on the DNA A, A point mutation is characterized by a change (insertion/deletion or substitution) of only 1 nucleotide base in a DNA sequence. B, A frame-shift mutation is caused by the insertion/deletion of a number of nucleotides in a DNA sequence that is not divisible by 3, which results in the change of the reading frame (the grouping of the codons) and, therefore, in a different translation from the original (different amino acid sequence).
Strauss. Spontaneous preterm birth, inflammation, and genetics. Am J Obstet Gynecol 2018. A common genetic substrate for spontaneous preterm labor/birth, periodontal disease, and inflammatory bowel disease Based on the discovery of mutations and predicted damaging missense variants, observed in PPROM cases, in genes previously linked to inflammatory bowel disease (CARD8, NOD2, TLR10, DEFB1, MBL2) and periodontal disease (DEFB1, MBL2), we propose that there is a common genetic substrate that underlies the association of inflammatory bowel disease, periodontal disease, and spontaneous preterm labor/birth. This model would predict that there is overlap in their occurrence because of a genetic commonality rather than a causal relationship as has been suggested for periodontal disease and preterm labor/birth ( Figure 9 ). Inflammatory bowel disease (Crohn's disease and ulcerative colitis) is associated with adverse pregnancy outcomes that include preterm labor/birth, smallfor-gestational-age birthweight, and congenital anomalies. [368] [369] [370] Pregnant women with inflammatory bowel disease, who have a high degree of disease activity, are at a much higher risk for preterm labor/birth than those who do not have disease activity during their pregnancy. [368] [369] [370] In contrast to preterm labor/birth, the genetics of inflammatory bowel disease have been well studied. GWAS have identified multiple loci that have been replicated and specific variants in genes that have been identified, as in the case of NOD2, in inflammatory bowel disease. 272, 371, 372 A genetic relationship between inflammatory bowel disease and preterm labor/birth has been suggested by others; however, it was heretofore not validated through mutation analysis. 373 Periodontal disease has been reported to be related to both inflammatory bowel disease and preterm labor/birth. Evidence from multiple cross-sectional studies shows that inflammatory bowel disease is associated with increased risk of periodontal disease. 374 Inflammatory bowel disease and periodontal disease are similar in that they are both related to an inappropriate immune response to a microbiota dysbiosis. The interaction between the 2 diseases appears to be complex, with 1 disease possibly altering the microbiota and influencing the inflammatory response of the other. 375 Most, but not all, studies have identified an association between preterm labor/birth and periodontal disease. Conflicting reports in the literature could be due to differences in the populations studied (eg, race/ethnicity) and the phenotypic characterization of cases and controls (eg, the clinical definition of periodontal disease). 376 Proposed links between preterm labor/birth and periodontal disease include (1) the translocation of bacteria to the placenta and amniotic fluid and (2) a systemic inflammatory response to periodontal disease that is chronic in nature. A recent study showed no association between periodontal disease status and microbial invasion of the amniotic cavity and intraamniotic inflammation. It is possible that the link between PPROM and periodontal disease could be through an exaggerated systemic inflammatory response; however, this requires further investigation. 377 The genetic contribution to periodontal disease has been explored in candidate gene association studies and GWAS. Some of these genetic studies on candidate genes identified associations with genes that we found had rare mutations and/or damaging missense variants in PPROM. 378 There are also overlapping environmental risk factors for preterm labor/ birth, inflammatory bowel disease, and periodontal disease. These environmental factors are thought to play key roles in the risk for preterm labor/birth. Classification of mutations based on their effect on the protein A, A nonsense mutation occurs when a sense codon that corresponds to 1 of the 20 amino acids is changed to a chain-terminating (Stop) codon. B, A missense mutation includes a single nucleotide change that results in a codon that codes for a different amino acid.
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We hypothesize that gene-environment interactions (eg, smoking) produce the phenotypes in preterm labor/birth as well as in inflammatory bowel disease and periodontal disease. Smoking increases the risk of preterm labor/birth. One proposed mechanism is that smoking increases the risk of PPROM by reducing immunity and predisposing the mother to infection. 379 In addition, smoking promotes periodontal disease 380 and influences inflammatory bowel disease; however, smoking affects Crohn's disease and ulcerative colitis differently. In Crohn's disease, tobacco use increases disease activity; in ulcerative colitis, tobacco is associated with a lower incidence of disease exacerbations, with smoking cessation even triggering flare-ups.
381
Nutrition is another environmental factor that influences preterm birth, inflammatory bowel disease, and periodontal disease. Plasma vitamin C levels have also been found to be lower in women with PPROM, which suggests that a relative deficiency of vitamin C may be a risk factor. 382 This may relate to the cofactor role of ascorbic acid in collagen biosynthesis and the impact of diminished lysyl hydroxylase activity on the tensile strength of the fetal membranes. Vitamin C deficiency has long been known to predispose periodontal disease. 383, 384 Ascorbic acid levels have also been shown to be decreased in patients with inflammatory bowel disease because of oxidative stress caused by inflammatory cells, thus reducing antioxidant buffering capacity and hindering the recovery of inflamed tissue. 385 The microbiota is a third environmental factor critical to the inflammation associated with chorioamnionitis, PPROM, inflammatory bowel disease, and periodontal disease, because pathogenic bacteria or viruses triggered the innate immune response targeted in a recent whole exome association study. 210 In some cases, specific bacteria are known to be critical to the disease (eg, Porphyromonas gingivalis in periodontal disease), whereas, in others, it is thought to be a microbial community state associated with inflammation (bacterial vaginosis, microorganisms in the amniotic cavity in cases of intraamniotic infection, and PPROM and preterm labor/birth). 
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The Supplementary Table provides information on the possible role of mutations or genetic variants shown in Crohn's disease, ulcerative colitis, and periodontal disease. Note that there are conflicting data, which may relate to the population studied or the genetic variant examined (the majority of the reports were candidate gene-association studies that examined polymorphisms in coding and noncoding regions, with the exception of the NOD2 frameshift mutation).
It is interesting that similar, but not necessarily identical, genes may be involved in these conditions. For example, NOD2 is strongly associated with inflammatory bowel disease and, apparently, PPROM, as shown by our data, but not with periodontal disease. Mutations or genetic variants in MBL2, however, appear to be associated with Crohn's disease, ulcerative colitis, periodontal disease, and PPROM.
An integrated view of the genetic commonality model
The genes that harbor rare mutations and damaging missense variants identified in a recent study, 210 and other genes that may have been missed, are candidates for other mechanisms of dysregulation that could result in the same consequences as inactivating mutations. One mechanism could be the epigenetic control of gene expression. Methylation of DNA promoter elements that regulate gene transcription can silence gene expression by preventing access of the transcription factors to the control elements. Gene expression can also be silenced by chromatin modification or the action of microRNAs, small noncoding RNA molecules that bind to microRNA and promote RNA destruction or prevent translation. The identification of a suite of genes tied to PPROM and other inflammatory conditions places a spotlight on these genes Basic mechanism of activation of the inflammasome in the chorioamniotic membranes Pathogen-associated molecular patterns and/or danger signals (ie, alarmins) in the amniotic cavity can induce the activation/assembly of the inflammasome complex (nucleotide oligomerization domain family pyrin domain containing protein [eg, NLRP3]þadaptor protein [ASC or apoptosis-associated speck-like protein]þprocaspase-1) in the chorioamniotic membranes. On activation, the inflammasome prompts the release of active forms of caspase-1 that, in turn, participate in the processing of mature interleukin-1b and -18 in the amniotic cavity.
ASC, apoptosis-associated speck-like protein; NLRP, nucleotide oligomerization domain family pyrin domain containing protein; PAMPs, pathogen-associated molecular patterns.
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as potential targets for epigenetic regulation, including DNA methylation, chromatin modification, and microRNAs.
Future challenges WES in PPROM did not determine the parent of origin of the mutant/damaging missense allele. However, we propose that maternal inheritance will be prominent, which would compromise innate immunity in both the maternal and the fetal compartments. This notion needs to be evaluated fully in future research.
The discovery that mutations in genes that encode host antimicrobial defense proteins raises interesting questions about the relationship of these mutations or any mechanism that silences their expression to the microbiota. It would be of interest to determine the impact of the mutations and damaging missense variants in host defense genes, eg, DEFB1 and MBL2, on the reproductive tract, gut, and oral microbiota. This information could help clarify whether an altered microbiota per se drives adverse outcomes, which include preterm labor/birth, or whether it is the host genome that shapes the microbiota composition and the host response.
Finally, we studied African American mothers, who have a higher incidence of preterm birth. 210 It remains to be determined whether the genetic commonality suggested by our findings, in conjunction with previously published reports that included diverse populations, are influenced by race/ ethnicity or genetic admixture. Are there population-specific mutations or damaging missense variants that could be used to predict adverse pregnancy outcome?
Conclusion
Collectively, the observations discussed in this extended editorial suggest that rare mutations or damaging missense variants in innate immunity genes play an important role in PPROM risk and that an overlapping genetic substrate could explain the occurrence of inflammatory conditions (inflammatory bowel disease and periodontal disease) in women who deliver preterm ( Figure 9 ).
Overlapping elements Overlapping gene mutations, damaging missense variants, and other polymorphisms in preterm premature rupture of the membranes, Crohn's disease, ulcerative colitis, and periodontal disease.
CARD, caspase recruitment domain; DEFB, defensin B1; MBL, mannose binding lectin; NLRP, nucleotide oligomerization domain-like receptor pyrin domain; NOD, nucleotide oligomerization domain; PPROM, preterm premature rupture of the membranes; TLR, toll-like receptor.
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Glossary
Whole exome sequencing (WES): DNA sequence analysis of exons, the protein-coding regions of genes. Genome-wide association study (GWAS): A study that uses thousands of single nucleotide polymorphisms that cover the entire human genome to map chromosomal regions associated with a trait by comparing the differences in the variant frequency in a large number of cases and controls.
Nonsense mutation: A DNA variation that results in a stop codon that terminates translation of the messenger RNA, which truncates the protein at the site of the stop codon.
Frameshift mutation: Either an insertion or a deletion of DNA bases that alters the reading frame of the encoded messenger RNA such that 1) it is truncated as a result of a stop codon or 2) the protein sequence is scrambled as a result of changes in the codon reading frame.
Missense variant: A DNA base change that alters a codon and results in an amino acid substitution in the translated protein.
Epigenetics: Regulation of gene expression by reversible chemical changes that do not involve alterations in a DNA sequence, such as the introduction of methyl groups into cytosine residues (DNA methylation) or the acetylation of lysine molecules of histone proteins that comprise chromatin, proteins bound to DNA (chromatin modification).
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